Cargando…

LOX-1, OxLDL, and Atherosclerosis

Oxidized low-density lipoprotein (OxLDL) contributes to the atherosclerotic plaque formation and progression by several mechanisms, including the induction of endothelial cell activation and dysfunction, macrophage foam cell formation, and smooth muscle cell migration and proliferation. Vascular wal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pirillo, Angela, Norata, Giuseppe Danilo, Catapano, Alberico Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723318/ https://www.ncbi.nlm.nih.gov/pubmed/23935243 http://dx.doi.org/10.1155/2013/152786

Ejemplares similares

Dyslipidemia-Induced Neuropathy in Mice: The Role of oxLDL/LOX-1
por: Vincent, Andrea M., et al.
Publicado: (2009)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives
por: Catapano, Alberico Luigi, et al.
Publicado: (2017)

Elucidation of the Role of Lectin-Like oxLDL Receptor-1 in the Metabolic Responses of Macrophages to Human oxLDL
por: Kimmel, Danielle W., et al.
Publicado: (2017)

Autophagic degradation of LOX-1 is involved in the maintenance of vascular integrity injured by oxLDL and protected by Berberine
por: Zheng, Yangmin, et al.
Publicado: (2023)

Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2021)

KAP1 silencing relieves OxLDL-induced vascular endothelial dysfunction by down-regulating LOX-1
por: Yan, Tianqing, et al.
Publicado: (2020)

Possible involvement of the oxLDL/LOX-1 system in the pathogenesis and progression of human intervertebral disc degeneration or herniation
por: Li, Xinhua, et al.
Publicado: (2017)

Molecular dynamics simulation of human LOX-1 provides an explanation for the lack of OxLDL binding to the Trp150Ala mutant
por: Falconi, Mattia, et al.
Publicado: (2007)

Impact of oxLDL on Cholesterol-Rich Membrane Rafts
por: Levitan, Irena, et al.
Publicado: (2011)

High density lipoproteins and atherosclerosis: emerging aspects
por: Sala, Federica, et al.
Publicado: (2012)

The association between serum levels of oxLDL-lgG and oxLDL-lgM autoantibody with adult acute myeloblastic leukaemia
por: Li, Hao, et al.
Publicado: (2010)

oxLDL and eLDL Induced Membrane Microdomains in Human Macrophages
por: Wallner, Stefan, et al.
Publicado: (2016)

Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases
por: Pirillo, Angela, et al.
Publicado: (2013)

Metformin regulates oxLDL-facilitated endothelial dysfunction by modulation of SIRT1 through repressing LOX-1-modulated oxidative signaling
por: Hung, Ching-Hsia, et al.
Publicado: (2016)

GDF-15 Suppresses Atherosclerosis by Inhibiting oxLDL-Induced Lipid Accumulation and Inflammation in Macrophages
por: Huang, Hong, et al.
Publicado: (2021)

CXCL16 and oxLDL are induced in the onset of diabetic nephropathy
por: Gutwein, Paul, et al.
Publicado: (2009)

OxLDL as an Inducer of a Metabolic Shift in Cancer Cells
por: Bitorina, Albert V., et al.
Publicado: (2021)

Early Transcriptomic Response to LDL and oxLDL in Human Vascular Smooth Muscle Cells
por: Damián-Zamacona, Salvador, et al.
Publicado: (2016)

oxLDL-Induced Trained Immunity Is Dependent on Mitochondrial Metabolic Reprogramming
por: Groh, Laszlo A., et al.
Publicado: (2021)

LXRα Regulates oxLDL-Induced Trained Immunity in Macrophages
por: Findeisen, Hannes M., et al.
Publicado: (2022)

Hyperoside inhibits the effects induced by oxidized low-density lipoprotein in vascular smooth muscle cells via oxLDL-LOX-1-ERK pathway
por: Zhang, Zhengyu, et al.
Publicado: (2017)

HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases
por: Bonacina, Fabrizia, et al.
Publicado: (2021)

Effect of Lipids and Lipoproteins on Hematopoietic Cell Metabolism and Commitment in Atherosclerosis
por: Baragetti, Andrea, et al.
Publicado: (2021)

Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors
por: Pirillo, Angela, et al.
Publicado: (2021)

The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation
por: Wang, Zhiwen, et al.
Publicado: (2022)

Reducing the Damage of Ox-LDL/LOX-1 Pathway to Vascular Endothelial Barrier Can Inhibit Atherosclerosis
por: Guo, Xiaopeng, et al.
Publicado: (2022)

Systems Approach to Study Associations between OxLDL and Abdominal Aortic Aneurysms
por: Gutowski, Łukasz, et al.
Publicado: (2019)

Early Transcriptomic Response to OxLDL in Human Retinal Pigment Epithelial Cells
por: Koirala, Diwa, et al.
Publicado: (2020)

Astragaloside IV Reduces OxLDL-Induced BNP Overexpression by Regulating HDAC
por: Zhang, Wenting, et al.
Publicado: (2021)

Immune modulatory effects of progesterone on oxLDL‐induced trained immunity in monocytes
por: Groh, Laszlo A., et al.
Publicado: (2022)

Exposure to oxLDL impairs TGF-β activity in human tendon cells
por: Mousavizadeh, Rouhollah, et al.
Publicado: (2023)

Calpain-1 Mediated Disorder of Pyrophosphate Metabolism Contributes to Vascular Calcification Induced by oxLDL
por: Tang, Futian, et al.
Publicado: (2015)

Mettl3 promotes oxLDL‐mediated inflammation through activating STAT1 signaling
por: Li, Zhenwei, et al.
Publicado: (2021)

Passive Immunization with Hypochlorite-oxLDL Specific Antibodies Reduces Plaque Volume in LDL Receptor-Deficient Mice
por: van Leeuwen, Marcella, et al.
Publicado: (2013)

Ethyl pyruvate inhibits oxidation of LDL in vitro and attenuates oxLDL toxicity in EA.hy926 cells
por: Rossmann, Christine, et al.
Publicado: (2018)

LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy
por: Amati, Francesca, et al.
Publicado: (2012)

oxLDL Downregulates the Dendritic Cell Homing Factors CCR7 and CCL21
por: Nickel, Thomas, et al.
Publicado: (2012)

Niacin Reverses Migratory Macrophage Foam Cell Arrest Mediated by oxLDL In Vitro
por: Huang, Hua, et al.
Publicado: (2014)

Endothelial ADAM10 controls cellular response to oxLDL and its deficiency exacerbates atherosclerosis with intraplaque hemorrhage and neovascularization in mice
por: van der Vorst, Emiel P. C., et al.
Publicado: (2023)

Impact of immunization against OxLDL on the pulmonary response to cigarette smoke exposure in mice
por: Talbot, Maude, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_61qedpinsevvivtbl0h163hlc9